GSK106（盐酸盐）是选择性 PAD4 抑制剂 GSK484 和 GSK199 的无活性对照。
| Cas No. | 1652591-82-6 |
| Canonical SMILES | NC1CN(C(C2=CC(N(C)C(C3=CC(C=CC=C4)=C4N3CC)=N5)=C5C=C2)=O)CCC1.Cl |
| 分子式 | C24H27N5O•HCl |
| 分子量 | 438 |
| 溶解度 | DMF: 30 mg/ml,DMSO: 30 mg/ml,Ethanol: 30 mg/ml,PBS (pH 7.2): 10 mg/ml |
| 储存条件 | Store at -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request |
| 产品描述 | Protein arginine deiminase 4 (PAD4) mediates the transformation of protein arginine into citrulline. Citrullination of proteins has normal roles in gene regulation and pathological roles in immunological and inflammatory diseases. GSK106 is an inactive control for the selective PAD4 inhibitors, GSK484 and GSK199 . It does not inhibit PAD4 nor does it prevent the citrullination of PAD4 target proteins or the formation of neutrophil extracellular traps in mouse or human neutrophils (IC50s >100 µM). See the Structural Genomics Consortium (SGC) website for more information on both GSK484 and GSK106. |
m.cnreagent.com